ERBB2 and neoplasm: We observed that tumors in both control and MARKO mice showed reduced gene expression of the steroid receptors Erα, Pr, Ar and their pioneer factor Foxa1. Our data suggest that ERBB2/ERBB3 driven tumorigenesis is opposed by AR and its loss results in earlier tumor development.